AU2003250099B2 - Endiandric acid H derivatives as c-maf inhibitors for using against asthma - Google Patents
Endiandric acid H derivatives as c-maf inhibitors for using against asthma Download PDFInfo
- Publication number
- AU2003250099B2 AU2003250099B2 AU2003250099A AU2003250099A AU2003250099B2 AU 2003250099 B2 AU2003250099 B2 AU 2003250099B2 AU 2003250099 A AU2003250099 A AU 2003250099A AU 2003250099 A AU2003250099 A AU 2003250099A AU 2003250099 B2 AU2003250099 B2 AU 2003250099B2
- Authority
- AU
- Australia
- Prior art keywords
- compound
- formula
- alkenyl
- alkyl
- branched
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
- C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
- C07D317/48—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
- C07D317/50—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to atoms of the carbocyclic ring
- C07D317/60—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Pulmonology (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
- Medicines Containing Plant Substances (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE10235624A DE10235624A1 (de) | 2002-08-02 | 2002-08-02 | Endiandric acid H und ihre Derivate, Verfahren zu ihrer Herstellung und Verwendung derselben |
| DE10235624.6 | 2002-08-02 | ||
| PCT/EP2003/007821 WO2004014888A1 (de) | 2002-08-02 | 2003-07-18 | Endiandric acid h derivate als c-maf inhibitoren zur verwendung gegen asthma |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| AU2003250099A1 AU2003250099A1 (en) | 2004-02-25 |
| AU2003250099B2 true AU2003250099B2 (en) | 2008-12-18 |
Family
ID=30469404
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2003250099A Ceased AU2003250099B2 (en) | 2002-08-02 | 2003-07-18 | Endiandric acid H derivatives as c-maf inhibitors for using against asthma |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US7019028B2 (https=) |
| EP (1) | EP1529040B1 (https=) |
| JP (1) | JP4598523B2 (https=) |
| AT (1) | ATE314359T1 (https=) |
| AU (1) | AU2003250099B2 (https=) |
| BR (1) | BR0313199A (https=) |
| CA (1) | CA2493483C (https=) |
| DE (2) | DE10235624A1 (https=) |
| DK (1) | DK1529040T3 (https=) |
| ES (1) | ES2254980T3 (https=) |
| IL (1) | IL166439A (https=) |
| MX (1) | MXPA05000387A (https=) |
| WO (1) | WO2004014888A1 (https=) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1944361A1 (en) | 2007-01-11 | 2008-07-16 | INSERM (Institut National de la Santé et de la Recherche Médicale) | A method for expanding monocytes |
| CN108192972B (zh) | 2010-10-06 | 2022-09-09 | 生物医学研究机构基金会 | 用于乳腺癌转移的诊断、预后和治疗的方法 |
| EP2650682A1 (en) | 2012-04-09 | 2013-10-16 | Fundació Privada Institut de Recerca Biomèdica | Method for the prognosis and treatment of cancer metastasis |
| BR112014030750A2 (pt) | 2012-06-06 | 2017-08-22 | Inst Catalana Recerca Estudis Avancats | Método para diagnóstico, prognóstico e tratamento da metástase do câncer pulmonar |
| US10119171B2 (en) | 2012-10-12 | 2018-11-06 | Inbiomotion S.L. | Method for the diagnosis, prognosis and treatment of prostate cancer metastasis |
| ES2906586T3 (es) | 2012-10-12 | 2022-04-19 | Inbiomotion Sl | Método para el diagnóstico, pronóstico y tratamiento de metástasis de cáncer de próstata |
| WO2015019125A1 (en) * | 2013-08-05 | 2015-02-12 | Societe De Developpement Et De Recherche Industrielle | Molecular targets for the treatment of wounds, in particular chronic wounds |
| US11596642B2 (en) | 2016-05-25 | 2023-03-07 | Inbiomotion S.L. | Therapeutic treatment of breast cancer based on c-MAF status |
| KR20200104298A (ko) | 2017-11-22 | 2020-09-03 | 인바이오모션 에스.엘. | c-MAF 상태에 기반한 유방암의 요법 치료 |
-
2002
- 2002-08-02 DE DE10235624A patent/DE10235624A1/de not_active Withdrawn
-
2003
- 2003-07-18 MX MXPA05000387A patent/MXPA05000387A/es active IP Right Grant
- 2003-07-18 EP EP03784025A patent/EP1529040B1/de not_active Expired - Lifetime
- 2003-07-18 DE DE50302084T patent/DE50302084D1/de not_active Expired - Lifetime
- 2003-07-18 WO PCT/EP2003/007821 patent/WO2004014888A1/de not_active Ceased
- 2003-07-18 ES ES03784025T patent/ES2254980T3/es not_active Expired - Lifetime
- 2003-07-18 AT AT03784025T patent/ATE314359T1/de active
- 2003-07-18 AU AU2003250099A patent/AU2003250099B2/en not_active Ceased
- 2003-07-18 CA CA2493483A patent/CA2493483C/en not_active Expired - Fee Related
- 2003-07-18 DK DK03784025T patent/DK1529040T3/da active
- 2003-07-18 JP JP2004526742A patent/JP4598523B2/ja not_active Expired - Fee Related
- 2003-07-18 BR BR0313199-8A patent/BR0313199A/pt not_active Application Discontinuation
- 2003-07-25 US US10/627,850 patent/US7019028B2/en not_active Expired - Fee Related
-
2005
- 2005-01-23 IL IL166439A patent/IL166439A/en not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| BR0313199A (pt) | 2005-06-21 |
| IL166439A (en) | 2009-12-24 |
| MXPA05000387A (es) | 2005-03-23 |
| IL166439A0 (en) | 2006-01-15 |
| US7019028B2 (en) | 2006-03-28 |
| DE50302084D1 (de) | 2006-02-02 |
| EP1529040B1 (de) | 2005-12-28 |
| DE10235624A1 (de) | 2004-02-19 |
| JP2006503006A (ja) | 2006-01-26 |
| ES2254980T3 (es) | 2006-06-16 |
| ATE314359T1 (de) | 2006-01-15 |
| DK1529040T3 (da) | 2006-05-08 |
| CA2493483A1 (en) | 2004-02-19 |
| US20040138313A1 (en) | 2004-07-15 |
| AU2003250099A1 (en) | 2004-02-25 |
| CA2493483C (en) | 2011-09-20 |
| JP4598523B2 (ja) | 2010-12-15 |
| EP1529040A1 (de) | 2005-05-11 |
| WO2004014888A1 (de) | 2004-02-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU617139B2 (en) | New phenylethanolamines | |
| AU2003250099B2 (en) | Endiandric acid H derivatives as c-maf inhibitors for using against asthma | |
| US4328309A (en) | Method for producing tripdiolide, triptolide and celastrol | |
| CN108840871B (zh) | 具有抗肿瘤活性的13-羟基金雀花碱肉桂酸酯类化合物及其制备方法 | |
| US4443619A (en) | Chlorocitric acids | |
| JP4077723B2 (ja) | クライネチンおよびその誘導体、調製方法および使用 | |
| JP5170608B2 (ja) | アフラトキシン生産阻害剤、及びそれを用いたアフラトキシン汚染防除方法 | |
| Chiji et al. | Two phenolic amides in the seed balls of sugar beet (Beta vulgaris L. var. saccharifera Alefeld) | |
| EP1416927A1 (en) | Sesquiterpenoid derivatives having adipocyte differentiation inhibitory effect | |
| US20020193316A1 (en) | Caloporoside derivatives, methods of their preparation and use | |
| KR20160050191A (ko) | 신규 네오리그난 화합물 | |
| CN118978453A (zh) | 根皮素衍生物及其制备方法和应用 | |
| CN121181624A (zh) | 一种新型生物碱类化合物Oreonudine G及其制备方法和应用 | |
| US4354039A (en) | Chlorocitric acids | |
| CN121872983A (zh) | 一种内酰胺生物碱自银合欢的制备方法及其在制备抗肿瘤药物中的应用 | |
| JP4469279B2 (ja) | ポリイソプレニルベンゾフェノン誘導体、その製造方法およびその使用 | |
| IL159561A (en) | Eurotinones and derivatives thereof, processes for preparing them and their use | |
| KR20130034458A (ko) | 벼 지상부 추출물, 벼 지상부 분획물, 이로부터 분리된 리그난 글리코시드 화합물 또는 이의 약학적으로 허용가능한 염을 유효성분으로 함유하는 염증성 질환의 예방 및 치료용 약학적 조성물 | |
| SK11802002A3 (sk) | Pluraflavíny a ich deriváty, spôsob ich prípravy a ich použitie | |
| Kato et al. | 2-AMINO-5-HYDROXYHEXANOIC ACID AND ITS SUCCINYL DERIVA-TIVES AS THEIR LACTONE FORMS FROM KOBUTORISOU, AN ANTAGONIZING PLANT TO NEMATODE | |
| AU1140500A (en) | Therapeutic compounds and methods | |
| JP2001342191A (ja) | ケトール脂肪酸誘導体およびその製造方法並びにこのケトール脂肪酸誘導体を有効成分とする植物成長調整剤 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PC1 | Assignment before grant (sect. 113) |
Owner name: SANOFI-AVENTIS DEUTSCHLAND GMBH Free format text: FORMER APPLICANT(S): AVENTIS PHARMA DEUTSCHLAND GMBH |
|
| FGA | Letters patent sealed or granted (standard patent) | ||
| MK14 | Patent ceased section 143(a) (annual fees not paid) or expired |